Company news
Clever Culture Systems Limited (ASX:CC5) news
Clever Culture Systems Limited news releases on 6ix. Latest, Jun 30, 2020: Results of Evaluation of APAS Independence by Johns Hopkins
Press releases — page 2
Results of Evaluation of APAS Independence by Johns Hopkins
June 30, 2020
First Sale of APAS Independence in United States
June 8, 2020
Update on MRSA Analysis Module US FDA Submission
June 3, 2020
$1.5M Draw Down on South Australian Government Loan
May 25, 2020
South Australian Government Agree to Extend Loan Facility
May 7, 2020
Presentation at NWR Virtual Small Cap Conference
April 29, 2020
US FDA 510(k) Submission for MRSA Analysis Module
March 29, 2020
VRE Analysis Module - Clinical Study Commenced
March 19, 2020
Johns Hopkins Hosp to Present Study Data APAS Independence
March 11, 2020
LBT Receives $1.1 Million R&D Tax Incentive
January 21, 2020
Presentation at Biotech Showcase Investor Conference
January 13, 2020
CEO Presentation - AGM 2019
November 27, 2019
Chairmans Address to Shareholders
November 27, 2019
Non-Executive Director Retirement
October 30, 2019
First European Sale of APAS Independence
October 21, 2019
LBT Presents at ExchangeSA Conference in Adelaide
September 25, 2019
MRSA Analysis Module CE Mark Registration
September 24, 2019
European Union Regulatory Certification & MRSA Study Results
September 15, 2019
Appendix 4E Full Year Report
August 29, 2019
Update on Distributor Appointments
July 21, 2019
South Australian Government Loan $1.5M Drawdown
June 26, 2019
First U.S. Clinical Data with APAS Presented at ASM Microbe
June 23, 2019
US Market Update
June 18, 2019
Information Required Under ASX Listing Rule 3.10.5A
June 11, 2019
$5M Oversubscribed Private Placement
June 5, 2019
APAS Independence Receives US FDA 510(k) Clearance
May 20, 2019
South Australian Government Loan - $1.0M Drawdown
May 8, 2019
Business Update Presentation
April 29, 2019
APAS Independence MRSA Study Results Presented at ECCMID
April 14, 2019
MRSA Analysis Module - Clinical Study Commenced
April 1, 2019
US FDA 510k Submitted for APAS Independence
December 20, 2018
LBT Presentation - 121 Tech Investment Conference, Singapore
December 2, 2018
CEO Presentation - AGM 2018
November 28, 2018
First Placement of APAS Independence into US Lab
November 25, 2018
Quarterly Activities & Cashflow Report - Appendix 4C
October 30, 2018
Company Presentation - Australian Non Deal Roadshow
September 16, 2018
Preliminary Final Report
August 30, 2018
Finalisation of SA Government Loan Facility Agreement
August 27, 2018
First Commercial Sale of APAS Independence
August 21, 2018
Quarterly Activities & Cash Flow Report - Appendix 4C
July 30, 2018
Market Update
June 28, 2018
Strategic Plan & Asset Review, WoundVue
June 5, 2018
First Placement of APAS Independence into European Lab
April 24, 2018
Share Purchase Plan Offer Document
March 14, 2018
$7m Oversubscribed Private Placement & Launch of $1m SPP
March 5, 2018
LBT Receives $4m Funding from South Australian Government
February 18, 2018
Quarterly Activities & Cash Flow Report (Appendix 4C)
January 29, 2018
$2.5M Grant Awarded to Advance WoundVue Development
December 6, 2017
Completion of Transaction with Autobio
December 1, 2017
St Vincents Hospital Completes APAS Independence Evaluation
November 28, 2017